Is chemical antithrombotic prophylaxis effective in elective thoracolumbar spine surgery? Results of a systematic review

Table of Contents

ABSTRACT

Study design: Systematic review

Study rationale and context: There is controversy regarding the efficacy and safety of chemical prophylaxis to prevent deep venous thrombosis (DVT) and pulmonary embolism (PE) in elective spinal procedures.Commonly performed elective spine surgeries done through a posterior approach have a very low associated risk of DVT/PE. The lack of consensus is due in part to a limited amount of quality evidence based literature dealing with this issue.

Objective: To compare chemical prophylaxis with no chemical prophylaxis in preventing venous thromboembolism in elective thoracolumbar spine surgery.

Methods: We undertook a systematic review of the literature to assess the efficacy and safety of chemical prophylaxis in preventing venous thromboembolism in elective thoracolumbar spine surgery. Pubmed, EMBASE, Cochrane, National Guideline Clearinghouse Databases as well as bibliographies of key articles were searched. Articles were reviewed by two independently working reviewers. Inclusion and exclusion criteria were set and each article was subject to a predefined quality rating scheme.

Results: We identified only two articles meeting our inclusion criteria. Neither study demonstrated a significant difference between chemical prophylaxis versus no prophylaxis in preventing thromboembolic events. There was an increased incidence of perioperative bleeding with low dose Coumadin in one of the studies.

Conclusion: The incidence of DVT and PE in commonly performed elective posterior spinal procedures is very low. While there is a limited amount of randomized literature looking at this issue, the current literature does not support the routine use of chemical prophylaxis for low risk patients undergoing these procedures.

Keywords: Venous thromboembolism, deep venous thrombosis, pulmonary embolism, chemical prophylaxis, spine surgery, bleeding

 

STUDY RATIONALE AND CONTEXT

There is a lack of consensus regarding the utility of chemical prophylaxis in preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing elective spine surgery. There is also concern for the possibility of increased perioperative bleeding with chemical prophylaxis [1], [2] in these patients.

OBJECTIVES

To compare chemical prophylaxis with no chemical prophylaxis in preventing venous thromboembolism in elective thoracolumbar spine surgery.

MATERIALS AND METHODS

Study design:

Systematic review

Sampling:

• Search: Pubmed, EMBASE, Cochrane, and National Guideline Clearinghouse Databases; bibliographies of key articles

• Dates searched: 1970–February 2010.

• Inclusion criteria

  • Elective thoracolumbar spine surgery, comparative studies assessing venous thromboembolic (VTE) complications

  Exclusion criteria

  • Nonelective thoracolumbar spine surgery (trauma, neoplasm), pediatric patients

  Outcomes: risk of VTE, risk of complications from anticoagulation therapy

• Analysis: descriptive statistics

Details about methods can be found in the web appendix at www.aospine.org / ebsj.

Figure 1 Flow chart showing results of literature search

 

Table 1 Study characteristics

 

RESULTS

We identified two small studies [3], [4] meeting our inclusion criteria (Fig. [1]). Both studies compared chemical prophylaxis to no chemical prophylaxis (Table [1]) and were prospective cohort studies, class of evidence II. Further details on the class of evidence rating for these studies can be found in the web appendix at www.aospine.org / ebsj.

Risk of VTE (Table [2])

• In two small prospective studies of elective thoracolumbar spine surgery, the risk of DVT in patients receiving chemical prophylaxis ranged from 0–4.0 % compared with 0 % in patients receiving either mechanical prophylaxis or placebo. Sample sizes for this relatively rare event were small.

• The risk of PE in elective thoracolumbar spine surgery is extremely low; no cases were identified from among 153 patients in two studies, regardless of chemical prophylaxis having been administered or not.

Risk of bleeding complications from anticoagulation therapy (Table [3])

• In two prospective studies, the risk of major intraoperative bleeding ranged from 0–3.1 % in patients receiving chemical prophylaxis compared with 0 % in patients receiving either mechanical prophylaxis or placebo.

• Minor intraoperative bleeding ranged from 3.1–24 % in those receiving chemical prophylaxis and 0–28 % in patients receiving either mechanical prophylaxis or placebo.

• There were no cases of hematoma in elective thoracolumbar spine surgery in patients receiving chemical prophylaxis in two prospective studies. The risk of hematomas among patients receiving either mechanical prophylaxis or placebo in two studies ranged from 0–4.0 %, however, no further surgery was required.

Table 2 Risk (%) of venous thromboembolism in thoracolumbar spine surgery comparing chemical prophylaxis with no chemical prophylaxis

 

Table 3 Risk (%) of bleeding complications comparing chemical prophylaxis with no chemical prophylaxis

 

EVIDENCE SUMMARY

 

Efficacy of chemical prophylaxis in elective thoracolumbar spine surgery

 

Bleeding complications of chemical prophylaxis in elective thoracolumbar spine surgery

 

CLINICAL GUIDELINES

In 2008, the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines provided recommendations for prevention of VTE in elective spinal surgery [5].

• For patients with no additional risk factors, recommendations are against the routine use of any thromboprophylactic modality beyond early and frequent ambulation.

• For patients with additional risk factors, any of the following prophylaxis recommendations are recommended:

  • Postoperative low-dose unfractionated heparin (LDUH) alone,

  • Postoperative low molecular weight heparin (LMWH) alone,

  • Perioperative intermittent compression stockings (IPC) alone,

  • Alternate considerations include perioperative graduated compression stockings (GCS).

  For patients with multiple risk factors for VTE, it is suggested that a pharmacologic preventative treatment (ie, LDUH or LMWH) be combined with the optimal use of a mechanical method (ie, GCS and / or IPC).

North American Spine Society Evidence-Based Guideline on Antithrombotic Therapies in Spine Surgery (2009) has provided evidence-based recommendations regarding antithrombotic therapies in elective spine surgery [6].

• Mechanical compression devices in the lower extremities are suggested, initiated just prior to surgery and continuing until the patient is fully ambulatory.

• Chemoprophylaxis may not be warranted in most common elective spine surgeries performed through a posterior approach.

• LMWH or LDUH may be used postoperatively following elective combined anterior-posterior spine surgery or in patients identified as having high risk for VTE, such as multiple trauma, malignancy or hypercoagulable state.

DISCUSSION

• This systematic review is limited by the small number of studies comparing chemical prophylaxis with no chemical prophylaxis in preventing VTE in elective thoracolumbar spine surgery. Additional limitations included disparate assessment of VTE between studies and inconsistent definitions and assessment of minor and major bleeding complications [7].

• Based on the available literature, there is little evidence to support the routine use of chemical prophylaxis in addition to mechanical prophylaxis devices in posterior approach elective spine surgeries. Chemical prophylaxis can be considered on a case by case basis in patients at higher risk for DVT such as those with advanced age, history of malignancy or previous VTE, presence of a neurologic deficit, inability to mobilize postoperatively, or an anterior thoraco-lumbar surgery. This approach is supported by the published guidelines of the North American Spine Society and American College of Chest Physicians [6].

• A comparison between the risks and benefits of chemical prophylaxis in this population would require more studies that are consistent in their study methodology.

ILLUSTRATIVE CASE

The patient is a 32-year-old otherwise healthy man with a left L5 radiculopathy. His sagittal (Figure [2]) and axial (Figure [3]) MRI scans show an L4–5 disc herniation consistent with his symptoms. He has had persistent symptoms despite conservative measures including epidural steroid injections. He is scheduled for a lumbar microdiscectomy. Compression stocking and pneumatic compression devises will be placed bilaterally after induction and left in place until the patient is out of bed ambulating. Because he has no other risk factors, no chemical prophylaxis is required.

Figure 2 Sagittal MRI

 

Figure 3 Axial MRI

 

REFERENCES

• 1 Voth D, Schwarz M, Hahn K. et al . Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.  Neurosurg Rev. 1992;  15(4) 289-294
• 2 Cheng , JS , Arnold P M, Anderson P A. et al . Anticoagulation risk in spine surgery.  Spine. 2010;  35(9S) S117-S124
• 3 Gruber U F, Rem J, Meisner C. et al . Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations.  Eur Arch Psychiatry Neurol Sci. 1984;  234(3) 157-161
• 4 Rokito S E, Schwartz M C, Neuwirth M G. Deep vein thrombosis after major reconstructive spinal surgery.  Spine. 1996;  21(7) 853-858; discussion 859
• 5 Geerts W H, Bergqvist D, Pineo G F. et al . Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest. 2008;  133(6 Suppl) 381S-453S
• 6 Committee NE-BGD .Evidence-Based Clinical Guidelines for Multidisciplinary Spine Care. Antithrombotic Therapies in Spine Surgery. Burr Ridge, IL: North American Spine Society 2009
• 7 Cheng J S, Arnold P M, Anderson P A. et al . Anticoagulation risk in spine surgery.  Spine. 2010;  35 (9S) S117-124.

EDITORIAL STAFF PERSPECTIVE

Thromboembolic events can lead to significant morbidity and mortality. Although this systematic review suggests the incidence of DVT and PE may be low in elective posterior spinal procedures, keeping in mind the major risk factors for thromboembolism is important. Some of the major risk factors for thromboembolism in general include:

• Spinal cord injury

• Fractures of hip or leg

• History of prior venous thromboembolism

• Polytrauma

• Neoplasia

• Major anterior lumbo-sacral surgery

• Hormone replacement therapy / oral contraceptive use

• Immobility (time period unclear)

• Increasing age

• Obesity

While this is not an extensive list, it provides a reminder that consideration of clinical circumstances in addition to consideration of the evidence is a necessary part of quality patient care.